Clinical Trials Logo

Clinical Trial Summary

Cryopreservation of embryos created during fresh IVF cycles provides a less expensive and time-intensive opportunity for pregnancy. Ideal endometrium thickness is the key point to optimization FET cycle. Researches show that when endometrial thickness is less than 7mm, pregnancy rate dropped significantly. Tamoxifen has been reported to be oestrogenic on the lower genital tract. Several study on intrauterine insemination or ovulation induction suggest that tamoxifen may be a promising alternative for patients with thin endometrium. Based on this ,we want to evaluate the effects of tamoxifen on endometrial thickness and pregnancy outcome in women who failed to develop an adequate endometrial thickness in previous frozen embryo transfer cycle twice or even more times and willing to have another attempt.


Clinical Trial Description

Objective: To investigate the effects of tamoxifen on endometrial thickness and pregnancy outcome in women with thin endometrium undergoing frozen thawed cycle.

Study design: This is a single center, randomize control clinical trial. We plan to recruit 100 patients from Mar 2017 to Dec 2019, who failed to develop an adequate endometrial thickness in previous frozen embryo transfer cycle twice or even more times and willing to have another attempt, dividing into two group, one prepare the endometrium through ovulation induction with tamoxifen and progesterone(Study Group), the other is hormone replacement cycle (control group).

Intervention: Study Group will give endometrial preparation with tamoxifen and progesterone, control group will prepared with estrogen and progesterone supplementation.

Main outcome measures: The primary outcome of the study was endometrium thickness and clinical pregnancy rate, the secondary outcomes are cycle duration, cycle cancellation rate, implantation rate, miscarriage rate, live birth rate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03060304
Study type Interventional
Source Sun Yat-sen University
Contact Xing Yang, M.D. & Ph.D.
Phone 020-38048013
Email yxing_8358@126.com
Status Not yet recruiting
Phase Phase 4
Start date March 2017
Completion date June 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00587886 - Estrogen, Diet, Genetics and Endometrial Cancer
Completed NCT03592849 - The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring N/A
Completed NCT01506778 - Tenaculum in Endometrial Sampling Procedure N/A
Completed NCT04854408 - Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns
Recruiting NCT04906551 - Measuring Endometrial Blood Flow Using Laser Doppler: Acceptability & Reproducibility
Completed NCT05375136 - A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
Completed NCT00827307 - Zoladex Plus Tamoxifen in Breast Cancer N/A
Completed NCT04288843 - Endometrial Dating by Ex-vivo Imaging of Endometrial Biopsies of In-vitro Fertilization Candidate Participants
Recruiting NCT01963819 - Therapeutic Endometrial Biopsy N/A
Recruiting NCT03081130 - Intravenous Laser Irradiation Effect on Treatment Resistant Thin Endometrium N/A
Completed NCT00436462 - Expression of Steroid Receptors in Endometrium N/A